Drug
Povidone-iodine solution
Povidone-iodine solution is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 50.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 1 completed trials
Completion Rate
50%(1/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_3
1
25%
Ph phase_2
3
75%
Phase Distribution
0
Early Stage
3
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
3(75.0%)
Phase 3Large-scale testing
1(25.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(1)
Terminated(1)
Other(1)
Detailed Status
Recruiting1
Completed1
Terminated1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
50.0%
Most Advanced
Phase 3
Trials by Phase
Phase 23 (75.0%)
Phase 31 (25.0%)
Trials by Status
recruiting125%
completed125%
terminated125%
unknown125%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_2
Topical 10% Povidone-Iodine in Preventing White Spots
NCT06616207
unknownphase_2
Trial of Antiseptic Irrigation for Pleural Infection
NCT05546762
completedphase_2
Povidone-iodine Versus Normal Saline Solution in Vaginal Cleansing in Laparoscopy
NCT02591251
terminatedphase_3
A Comparison of Surgical Preparations and Wound Infection Rates for Elective Cesarean Sections
NCT00528008
Clinical Trials (4)
Showing 4 of 4 trials
NCT06616207Phase 2
Topical 10% Povidone-Iodine in Preventing White Spots
NCT05546762Phase 2
Trial of Antiseptic Irrigation for Pleural Infection
NCT02591251Phase 2
Povidone-iodine Versus Normal Saline Solution in Vaginal Cleansing in Laparoscopy
NCT00528008Phase 3
A Comparison of Surgical Preparations and Wound Infection Rates for Elective Cesarean Sections
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4